Jul. 12 at 6:18 PM
$ABCL
A subtle signal, but one I view as extremely bullish.
Hansen effectively ruled out the idea of
$ABCL being acquired. His focus is on building a global company, not creating a short-term exit opportunity.
He believes Canada needs to build world-class enterprises if it wants to compete globally.
That kind of long-term vision from leadership is rare, and for a biotech company still in the growth phase, the CEO’s strategic mindset matters.
